Assertio to Present at the Stifel 2020 Virtual Healthcare Conference on November 17, 2020
Assertio Holdings, Inc. (Nasdaq: ASRT) announced that President and CEO Todd Smith will present at the Stifel 2020 Virtual Healthcare Conference on November 17, 2020, at 11:20 am ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Assertio Holdings, Inc. (Nasdaq: ASRT) announced that President and CEO Todd Smith will present at the Stifel 2020 Virtual Healthcare Conference on November 17, 2020, at 11:20 am ET. Investors can access a live audio webcast of the presentation on the Company’s website, with a replay available afterward. Assertio focuses on delivering differentiated pharmaceutical products, with a strong portfolio in neurology, hospital, and pain inflammation. The Company has expanded through licensing, mergers, and acquisitions, aiming to be the partner of choice in healthcare.
Details
News Market Reaction – ASRT
The recorded move for ASRT in the trading session of this news was -2.82%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
LAKE FOREST, Ill., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a commercial-stage pharmaceutical company, announced that President, chief executive officer and director, Todd Smith will present at and participate in investor meetings at the Stifel 2020 Virtual Healthcare Conference on November 17, 2020. The presentation will take place at 11:20 am ET
A live audio webcast of the presentation can be accessed through the Investors section of the Company's website at www.assertiotx.com. A replay of the webcast will be available on the Company's website following the live presentation.
About Assertio
Assertio is a leading commercial pharmaceutical company bringing differentiated products to patients. The Company has a robust portfolio of branded prescription products in three areas: neurology, hospital and pain and inflammation. Assertio has grown through business development including licensing, mergers and acquisitions. The Company seeks to leverage its commercial excellence to be the partner of choice. To learn more about Assertio, visit www.assertiotx.com.
Investor Contact
Lee Roth
Burns McClellan for Assertio Holdings, Inc.
lroth@burnsmc.com
ir@assertiotx.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.